Sonic Healthcare Ltd
ASX:SHL

Watchlist Manager
Sonic Healthcare Ltd Logo
Sonic Healthcare Ltd
ASX:SHL
Watchlist
Price: 27.44 AUD 0.11% Market Closed
Market Cap: 13.2B AUD
Have any thoughts about
Sonic Healthcare Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one SHL stock under the Base Case scenario is 44.79 AUD. Compared to the current market price of 27.44 AUD, Sonic Healthcare Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHL Relative Value
Base Case
44.79 AUD
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
84
vs Industry
56
Median 3Y
1.7
Median 5Y
1.8
Industry
2.3
Forward
1.4
More Details
25.8
P/E
P/E
Price to Earnings
25.8
vs History
11
vs Industry
22
Median 3Y
16.5
Median 5Y
19.8
Industry
23.2
Forward
25
More Details
12.3
P/OCF
P/OCF
Price to OCF
12.3
vs History
7
vs Industry
32
Median 3Y
9.3
Median 5Y
9.7
Industry
14.3
More Details
8.5
P/FCFE
P/FCFE
Price to FCFE
8.5
vs History
88
vs Industry
32
Median 3Y
13.6
Median 5Y
16.3
Industry
20.1
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
85
vs Industry
48
Median 3Y
2
Median 5Y
2.2
Industry
2.2
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
77
vs Industry
52
Median 3Y
1.9
Median 5Y
2.1
Industry
2.4
Forward
1.7
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
77
vs Industry
67
Median 3Y
2.3
Median 5Y
2.6
Industry
5
More Details
19.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.3
vs History
15
vs Industry
18
Median 3Y
12.3
Median 5Y
15.3
Industry
12.8
Forward
9.3
More Details
19.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.3
vs History
15
vs Industry
24
Median 3Y
12.3
Median 5Y
15.3
Industry
17.2
Forward
17.7
More Details
15.3
EV/OCF
EV/OCF
Enterprise Value to OCF
15.3
vs History
6
vs Industry
29
Median 3Y
10.5
Median 5Y
11.2
Industry
14
More Details
33.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
33.3
vs History
1
vs Industry
18
Median 3Y
12.8
Median 5Y
16
Industry
18.2
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
87
vs Industry
52
Median 3Y
1.5
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

SHL Competitors Multiples
Sonic Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Sonic Healthcare Ltd
ASX:SHL
13.2B AUD 1.5 25.8 19.3 19.3
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1
P/E Multiple
Earnings Growth PEG
AU
Sonic Healthcare Ltd
ASX:SHL
Average P/E: 26.9
25.8
11%
2.3
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
Cigna Corp
NYSE:CI
25.6
25%
1
US
CVS Health Corp
NYSE:CVS
11.2
3%
3.7
DE
Fresenius Medical Care AG
XMUN:FME
49
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.3
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.4
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.5
31%
0.8
US
DaVita Inc
NYSE:DVA
15.4
17%
0.9

See Also

Summary
SHL intrinsic value, competitors valuation, and company profile.
DCF Valuation
SHL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SHL stock valuation using valuation multiples.
Wall Street Estimates
SHL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SHL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.